CervoMed, Inc. (CRVO)
2.44
+0.01
(+0.41%)
USD |
NASDAQ |
Sep 21, 16:00
2.44
0.00 (0.00%)
After-Hours: 20:00
CervoMed Total Liabilities (Quarterly) : 3.032M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.032M |
| March 31, 2026 | 4.497M |
| December 31, 2025 | 5.177M |
| September 30, 2025 | 4.599M |
| June 30, 2025 | 4.642M |
| March 31, 2025 | 3.943M |
| December 31, 2024 | 4.253M |
| September 30, 2024 | 3.246M |
| June 30, 2024 | 3.214M |
| March 31, 2024 | 2.661M |
| December 31, 2023 | 2.596M |
| September 30, 2023 | 2.464M |
| June 30, 2023 | 1.465M |
| March 31, 2023 | 2.126M |
| December 31, 2022 | 37.44M |
| September 30, 2022 | 2.271M |
| June 30, 2022 | 2.515M |
| March 31, 2022 | 2.956M |
| December 31, 2021 | 2.928M |
| September 30, 2021 | 2.749M |
| June 30, 2021 | 2.544M |
| March 31, 2021 | 2.566M |
| December 31, 2020 | 4.734M |
| September 30, 2020 | 3.193M |
| June 30, 2020 | 3.116M |
| Date | Value |
|---|---|
| March 31, 2020 | 3.156M |
| December 31, 2019 | 4.144M |
| September 30, 2019 | 2.678M |
| June 30, 2019 | 2.752M |
| March 31, 2019 | 3.033M |
| December 31, 2018 | 3.028M |
| September 30, 2018 | 2.687M |
| June 30, 2018 | 2.644M |
| March 31, 2018 | 3.646M |
| December 31, 2017 | 4.916M |
| September 30, 2017 | 21.97M |
| June 30, 2017 | 32.74M |
| March 31, 2017 | 55.46M |
| December 31, 2016 | 8.300M |
| September 30, 2016 | 7.561M |
| June 30, 2016 | 5.892M |
| March 31, 2016 | 6.332M |
| December 31, 2015 | 3.478M |
| September 30, 2015 | 4.309M |
| June 30, 2015 | 4.842M |
| March 31, 2015 | 4.368M |
| December 31, 2014 | 4.613M |
| September 30, 2014 | 7.748M |
| June 30, 2014 | 9.232M |
| March 31, 2014 | 14.23M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
| Vericel Corp. | 132.82M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 25.99M |
| Shareholders Equity (Quarterly) | 22.96M |
| Current Ratio | 8.466 |